Does INFIGRATINIB Cause Off label use? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Off label use have been filed in association with INFIGRATINIB. This represents 16.4% of all adverse event reports for INFIGRATINIB.
11
Reports of Off label use with INFIGRATINIB
16.4%
of all INFIGRATINIB reports
3
Deaths
2
Hospitalizations
How Dangerous Is Off label use From INFIGRATINIB?
Of the 11 reports, 3 (27.3%) resulted in death, 2 (18.2%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFIGRATINIB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does INFIGRATINIB Cause?
Fatigue (16)
Stomatitis (12)
Alopecia (10)
Decreased appetite (10)
Diarrhoea (10)
Nausea (9)
Blood phosphorus increased (8)
Skin exfoliation (8)
Vomiting (8)
Death (7)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)